Skip to main content

Assessment of type of allergy and antihistamine use in the development of glioma.

Publication ,  Journal Article
McCarthy, BJ; Rankin, K; Il'yasova, D; Erdal, S; Vick, N; Ali-Osman, F; Bigner, DD; Davis, F
Published in: Cancer Epidemiol Biomarkers Prev
February 2011

BACKGROUND: Allergies have been associated with decreased risk of glioma; but, associations between duration and timing of allergies, and antihistamine use and glioma risk have been less consistent. The objective was to investigate this association by analyzing types, number, years since diagnosis, and age at diagnosis of allergies, and information on antihistamine usage, including type, duration, and frequency of exposure. METHODS: Self-report data on medically diagnosed allergies and antihistamine use were obtained for 419 glioma cases and 612 hospital-based controls from Duke University and NorthShore University HealthSystem. RESULTS: High- and low-grade glioma cases were statistically significantly less likely to report any allergy than controls (OR = 0.66, 95% CI: 0.49-0.87 and OR = 0.44, 95% CI: 0.25-0.76, respectively). The number of types of allergies (seasonal, medication, pet, food, and other) was inversely associated with glioma risk in a dose-response manner (P value for trend < 0.05). Age at diagnosis and years since diagnosis of allergies were not associated with glioma risk. Oral antihistamine use was statistically significantly inversely associated with glioma risk, but when stratified by allergy status, remained significant only for those with high-grade glioma and no medically diagnosed allergy. CONCLUSIONS: All types of allergies appear to be protective with reduced risk for those with more types of allergies. Antihistamine use, other than in relationship with allergy status, may not influence glioma risk. IMPACT: A comprehensive study of allergies and antihistamine use using standardized questions and biological markers will be essential to further delineate the biological mechanism that may be involved in brain tumor development.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

February 2011

Volume

20

Issue

2

Start / End Page

370 / 378

Location

United States

Related Subject Headings

  • Young Adult
  • United States
  • Risk Factors
  • Prognosis
  • Middle Aged
  • Male
  • Hypersensitivity
  • Humans
  • Histamine H1 Antagonists
  • Glioma
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McCarthy, B. J., Rankin, K., Il’yasova, D., Erdal, S., Vick, N., Ali-Osman, F., … Davis, F. (2011). Assessment of type of allergy and antihistamine use in the development of glioma. Cancer Epidemiol Biomarkers Prev, 20(2), 370–378. https://doi.org/10.1158/1055-9965.EPI-10-0948
McCarthy, Bridget J., Kristin Rankin, Dora Il’yasova, Serap Erdal, Nicholas Vick, Francis Ali-Osman, Darell D. Bigner, and Faith Davis. “Assessment of type of allergy and antihistamine use in the development of glioma.Cancer Epidemiol Biomarkers Prev 20, no. 2 (February 2011): 370–78. https://doi.org/10.1158/1055-9965.EPI-10-0948.
McCarthy BJ, Rankin K, Il’yasova D, Erdal S, Vick N, Ali-Osman F, et al. Assessment of type of allergy and antihistamine use in the development of glioma. Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):370–8.
McCarthy, Bridget J., et al. “Assessment of type of allergy and antihistamine use in the development of glioma.Cancer Epidemiol Biomarkers Prev, vol. 20, no. 2, Feb. 2011, pp. 370–78. Pubmed, doi:10.1158/1055-9965.EPI-10-0948.
McCarthy BJ, Rankin K, Il’yasova D, Erdal S, Vick N, Ali-Osman F, Bigner DD, Davis F. Assessment of type of allergy and antihistamine use in the development of glioma. Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):370–378.

Published In

Cancer Epidemiol Biomarkers Prev

DOI

EISSN

1538-7755

Publication Date

February 2011

Volume

20

Issue

2

Start / End Page

370 / 378

Location

United States

Related Subject Headings

  • Young Adult
  • United States
  • Risk Factors
  • Prognosis
  • Middle Aged
  • Male
  • Hypersensitivity
  • Humans
  • Histamine H1 Antagonists
  • Glioma